DOI: 10.1001/jamadermatol.2026.1907 ISSN: 2168-6068
GLP-1 Receptor Agonist Use and Clinical Outcomes in Patients With Hidradenitis Suppurativa
Beata Jastrząb-Miśkiewicz, Jacek C. Szepietowski, Piotr K. KrajewskiThis cohort study examines mortality, major cardiovascular events, and systemic complications in persons with hidradenitis suppurativa taking glucagon-like peptide-1 (GLP-1) receptor agonists.